b9
13
d
d
69
f
15
1
1
1
24
19
38
11
17
1
15
15
11
3a
9
13
d
9
9
19
9
d
11
9
9
11
9
13
19
19
49
19
19
18
1 18
1 1 1 2b
11
15
11
15
25
11
11
11
18
2a Karishma Khullar, MD
1 19 19 31 19 65 19 19 49 31 31 19 19 19 19 19 45
3b
19
19
19
1
1
1
1
2d
92
2f
1
1
5
2f
4c
7
Assistant Professor of Clinical Radiation Oncology
1874 Department: Radiation Oncology
11 131 18
e
1
5
25
5
9
e
Contact Information
c
92
3400 Civic Center Boulevard
Philadelphia, PA 19104
49
17
9
12
Links
d b
1b
b
Education
d-
1d
-
3b
BA (Health and Societies)
56
University of Pennsylvania, 2012
1d
-
25
MD
68
University of Cincinnati College of Medicine, 2017
1a
1 1 1 2b
Description of Research Expertise
1fHealthcare disparities
1 2bDescription of Clinical Expertise
29Radiotherapy for GI malignancies
1 1 1 1fSelected Publications
5-
5
- 155 J Fu, A Pepin, C Hollawell, S Appel, K Tang, J S Bryer, A Munter, R Maxwell, A Lin, S Feigenberg, J Bradley, W Levin, K Khullar, J Metz, J P Plastaras, A Goel : Feasibility and Baseline Characteristics in a Phase II Single Institution Continuous Activity Monitoring (CAM 2.0) Trial for Patients Undergoing Chemoradiation 34 ACRO 2026 Summit February 2026 5
- 100 Perlow HK, Khullar K, Kumar R, Sasmal S, Nakamoto K, Gokun Y, Eckstein J, Young R, Diaz DA, Martin D, et al : Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer. 16 Current Oncology 2 27 32(6) : 353, June 2025 5
- e3 Khullar K, Deek RA, Nelson B, Gaines D, Corrigan KL, LeCompte MC, Deville C Jr, Deek MP, Jabbour SK. : Gender and the Receipt of the Association of Residents in Radiation Oncology Educator of the Year Award 3c Adv Radiat Oncol 9(1) : 101305, Oct 2023 5
- b1 Khullar K, Plascak JJ, Parikh RR : Acute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility 41 Leukemia & Lymphoma 63(1) : 170-178, Sep 2021 5
- d5 Khullar K, Hanft S, Mehnert JM, Weiner JP : Complete response of brainstem metastasis in BRAF-mutated melanoma without stereotactic radiosurgery after initiation of encorafenib and binimetinib 3a Melanoma Res 31(4) : 393-396, Aug 2021 5
- 151 Modi C, Dragun AE, Henson CF, Jain S, Ahlawat S, Eastwick G, Kubicek GJ, Mezera M, Mulvihill DJ, Perri J, Juneja B, Khullar K, Ennis RD, Haffty BG : A Statewide Multi-Institutional Study of Asymptomatic Pretreatment Testing of Radiation Therapy Patients for SARS-CoV-2 in a High-Incidence Region of the United States 40 Adv Radiat Oncol 6(4) : 100704, Jul-Aug 2021 5
- a6 Khullar K, Dhawan ST, Nosher J, Jabbour SK : Fiducial marker migration following computed tomography-guided placement in the liver: a case report 35 AME Case Reports 5 : 15, Apr 2021 5
- 63 Khullar K & Parikh RR : The role of radiotherapy in metastatic prostate cancer 3d Am J Clin Exp Urol 7(2) : 92-97, Apr 2021 5
- ad Khullar K, Plasack JJ, Drachtman R, Cole PD, Parikh RR : Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma 3f Cancer Medicine 10(4) : 1327-1334, Feb 2021 5
- 152 Wang SJ, Khullar K, Kim S, Crayton SH, Yegya-Raman N, Groisberg R, Silk AW, Nosher JL, Malhotra J, Gentile MA, Mehnert JM, Jabbour SK. : Cyclooxygenase inhibitor use during checkpoint immunotherapy and effect on time to progression and overall survival for metastatic melanoma and non-small cell lung cancer patients. 42 Journal for ImmunoTherapy of Cancer Oct 2020 6